I agree that this site is using cookies. You can find further informations here.
X
Nagata, Naoki
744  results:
Search for persons X
?
1

Multicenter phase II study of capecitabine plus oxaliplatin..:

Kawabata, Ryohei ; Chin, Keisho ; Takahari, Daisuke...
Gastric Cancer.  26 (2023)  6 - p. 1020-1029 , 2023
Link: https://doi.org/10.1007/..
 
?
2

Multicenter, single‐arm, phase II study of the continuous u..:

Watanabe, Jun ; Maeda, Hiromichi ; Nagasaka, Takeshi...
International Journal of Cancer.  151 (2022)  12 - p. 2172-2181 , 2022
Link: https://doi.org/10.1002/..
 
?
3

Invasive cribriform carcinoma of the breast detected incide..:

Adachi, Yasuhiro ; Katsuki, Takefumi ; Sasaguri, Takakazu..
Clinical Case Reports.  9 (2021)  12 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
4

Phase II study of an oxaliplatin-based regimen for relapsed..:

Ishibashi, Keiichiro ; Aoyama, Toru ; Kotaka, Masahito...
Cancer Chemotherapy and Pharmacology.  87 (2021)  5 - p. 665-672 , 2021
Link: https://doi.org/10.1007/..
 
?
5

A placebo-controlled, double-blind, randomized study of rec..:

Kotaka, Masahito ; Saito, Yoji ; Kato, Takeshi...
Cancer Chemotherapy and Pharmacology.  86 (2020)  5 - p. 607-618 , 2020
Link: https://doi.org/10.1007/..
 
?
6

Phase Ib/II Study of Biweekly TAS-102 in Combination with B..:

Satake, Hironaga ; Kato, Takeshi ; Oba, Koji...
The Oncologist.  25 (2020)  12 - p. e1855-e1863 , 2020
Link: https://doi.org/10.1634/..
 
?
7

Correction to: A placebo‑controlled, double‑blind, randomiz..:

Kotaka, Masahito ; Saito, Yoji ; Kato, Takeshi...
Cancer Chemotherapy and Pharmacology.  87 (2020)  4 - p. 585-586 , 2020
Link: https://doi.org/10.1007/..
 
?
8

Multicenter open-label randomized phase II study of second-..:

Nagata, Naoki ; Maeda, Hiromichi ; Ishibashi, Keiichiro...
Medical Oncology.  36 (2019)  6 - p. , 2019
Link: https://doi.org/10.1007/..
 
?
9

The clinical impact of Hangeshashinto (TJ-14) in the treatm..:

Nishikawa, Kazuhiro ; Aoyama, Toru ; Oba, Mari S...
Journal of Cancer.  9 (2018)  10 - p. 1725-1730 , 2018
Link: https://doi.org/10.7150/..
 
?
10

The prognostic significance of the expression of monocarbox..:

Abe, Yukio ; Nakayama, Yoshifumi ; Katsuki, Takefumi...
Asia-Pacific Journal of Clinical Oncology.  15 (2018)  2 - p. , 2018
Link: https://doi.org/10.1111/..
 
?
11

Efficacy of CapeOX plus Cetuximab Treatment as a First-Line..:

Iwamoto, Shigeyoshi ; Maeda, Hiromichi ; Hazama, Shoichi...
Journal of Cancer.  9 (2018)  22 - p. 4092-4098 , 2018
Link: https://doi.org/10.7150/..
 
?
12

A phase II trial to evaluate the efficacy of panitumumab co..:

Munemoto, Yoshinori ; Kanda, Mitsuro ; Oba, Koji...
Cancer Chemotherapy and Pharmacology.  81 (2018)  5 - p. 829-838 , 2018
Link: https://doi.org/10.1007/..
 
?
13

Meta-analysis of Patient-level Data on Therapeutic Effects ..:

Aoyama, Toru ; Nishikawa, Kazuhiro ; Oba, Mari...
Annals of Cancer Research and Therapy.  25 (2017)  2 - p. 92-94 , 2017
Link: https://doi.org/10.4993/..
 
?
14

mFOLFOX6 Plus Panitumumab Versus 5-FU/LV Plus Panitumumab A..:

Nagata, Naoki ; Mishima, Hideyuki ; Kurosawa, Shuichi..
Clinical Colorectal Cancer.  16 (2017)  2 - p. 154-157.e1 , 2017
Link: https://doi.org/10.1016/..
 
?
15

A Phase II Study of Third-Line Combination Chemotherapy wit..:

Yoshida, Motoki ; Takagane, Akinori ; Miyake, Yasuhiro...
Oncology.  91 (2016)  1 - p. 24-30 , 2016
Link: https://doi.org/10.1159/..
 
1-15